🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

10 results for “Vistagen Therapeutics” Clear

  1. Fasedienol Nasal Spray

    Vistagen Therapeutics

    Social Anxiety Disorder

    phase 3 small molecule active

    1 trial
  2. Fasedienol Nasal Spray

    Vistagen Therapeutics

    Social Anxiety Disorder (SAD)

    phase 3 small molecule active

    1 trial
  3. PH94B

    Vistagen Therapeutics

    Social Anxiety Disorder

    phase 3 small molecule terminated

    1 trial
  4. PH94B Nasal Spray

    Vistagen Therapeutics

    Social Anxiety Disorder

    phase 3 small molecule terminated

    2 trials
  5. AV-101

    Vistagen Therapeutics

    Parkinson Disease

    phase 2 small molecule active

    1 trial
  6. AV-101

    Vistagen Therapeutics

    Major Depressive Disorder

    phase 2 small molecule completed

    1 trial
  7. Fasedienol Nasal Spray - Placebo Nasal Spray

    Vistagen Therapeutics

    Social Anxiety Disorder

    phase 2 small molecule active

    1 trial
  8. PH94B

    Vistagen Therapeutics

    Adjustment Disorder With Anxious Mood

    phase 2 small molecule completed

    1 trial
  9. Placebo

    Vistagen Therapeutics

    Healthy

    phase 2 small molecule completed

    1 trial
  10. AV-101

    Vistagen Therapeutics

    Drug Drug Interaction

    phase 1 small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources